The post-LASIK cornea: what's the damage?

Globally, LASIK is a very popular refractive procedure, which provides excellent visual acuity and quality of vision in low to moderate myopia and hyperopia.1 In the mid-nineties, however, LASIK was performed even in extreme myopic errors (up to 23D) or in corneas that were too thin with or without Forme Fruste Keratoconus (FFKC).

The excimer laser used for the refractive procedures was the C217 Technolas with Planoscan software (Bausch & Lomb). The Automated Corneal Shaper (ACS) microkeratome (Chiron) was used from 1996 to 1999 while the Hansatome microkeratome (Bausch & Lomb) was used in procedures performed since 1999. Flap thickness was considered to be the same as the microkeratome plates (160 µm to 180 µm). In addition, we re-evaluated three eyes in which we had to remove the corneal flap (DLK in two eyes; epithelial ingrowth in one eye) resulting in a total residual corneal thickness <350 µm.

Residual Stromal Bed (RSB) thickness was calculated according to available data. If preoperative pachymetry were known, we subtracted predicted flap thickness and calculated ablation depth. If it were unknown, we would make a postoperative pachymetry measurement using Orbscan and subtract the predicted flap thickness.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Investigating better indications and outcomes in laser refractive surgery
Avoiding errors when converting to DMEK
EDOF lens tech is evolving to help more patients with intermediate vision
Fixoflex ring: Prof. Pallikaris describes how to utilise the device during IOL implantation
Advancing IOL technology for treatment of presbyopia
Dexamethasone insert reduces time spent planning cataract surgery, counselling patients
Addressing gaps in vision care with a wearable diagnostic platform
Presbyopia-correcting drops provide hope for frustrated patients
Related Content
© 2023 MJH Life Sciences

All rights reserved.